Related Experiment Videos
Transoral laser surgery for early glottic carcinoma
H E Eckel1, W Thumfart, M Jungehülsing
1Department of Otorhinolaryngology, University of Cologne, Germany. hans.eckel@uni-koeln.de
Summary
Transoral laser surgery (TLS) offers favorable oncological outcomes for early glottic cancer, achieving high survival and organ preservation rates. This study supports TLS as an effective treatment option for glottic carcinoma.
Area of Science:
- Otolaryngology
- Oncology
- Surgical Oncology
Background:
- Transoral laser surgery (TLS) is a standard approach for glottic carcinoma at a university referral center.
- The study includes a large cohort of 285 patients with Tis, T1, and T2 glottic tumors.
Purpose of the Study:
- To evaluate the oncological outcomes of TLS for early-stage glottic carcinoma.
- To assess local control, regional control, organ preservation, and survival rates after TLS.
Main Methods:
- Prospective study of 285 consecutive patients treated between 1987 and 1996.
- Data collection on Tis, T1, and T2 glottic carcinoma treated with TLS.
- Analysis of oncological outcomes including local and regional control, survival, and organ preservation.
Main Results:
- 5-year actuarial survival was 71.1% overall and 98.7% cause-specific.
- Initial local control was 85.9%, with ultimate local control reaching 98.5% after salvage.
- Regional control was 98.4%, and laryngeal preservation was achieved in 94.3% of patients at 5 years.
Conclusions:
- TLS demonstrates favorable oncological results for early glottic carcinoma.
- While TLS is effective, no single treatment is definitively superior; patient-specific needs should guide modality selection.
- Partial laryngectomies offer high local control, radiotherapy excels in voice preservation, and TLS provides cost-effectiveness and good re-treatment options.